PLEIOTROPIC EFFECTS OF SIMVASTATIN AND FENOFIBRATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A COMPARATIVE STUDY

We compared clinical efficacy and safety of simvastatin (40 mg daily) for 12 weeks (n = 33, group 1) vs fenofibrate (145 mg daily) for 12 weeks (n = 33, group 2) in patients with active RA taking stable doses of DMARDs. Changes in the Disease Activity Score (DAS28) with 28 joints count was the prima...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: I. V. Shirinsky, N. Yu. Kalinovskaya, V. S. Shirinsky
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2019
Materias:
Acceso en línea:https://doaj.org/article/58336e98a8784ef2be4d26bf0920e649
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!